CAPSTONE INVESTMENT ADVISORS, LLC
Position in MAZE — Maze Therapeutics, Inc.
CIK 1426196
NEW YORK, NY
Position in MAZE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$272,799
New position
Shares Held
9,139
first reported quarter
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPSTONE INVESTMENT ADVISORS, LLC holds $45,989,751 across 38 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
120,000 | $15,927,600 | |
| 2 | TECH |
BIO-TECHNE Corp
|
210,000 | $14,836,500 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
7,200 | $1,348,416 | |
| 4 | RXRX |
Recursion Pharmaceuticals, Inc.
|
222,378 | $816,127 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,240 | $773,189 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,448 | $719,265 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
12,611 | $692,848 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,899 | $571,655 |
All Filings in MAZE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $272,799 | 9,139 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||